We have located links that may give you full text access.
Pulmonary aspergilloma and pulmonary tuberculosis: is there a strong association?
Chest 2014 March 2
SESSION TITLE: Respiratory InfectionsSESSION TYPE: Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: Aspergillus spp. is a ubiquitous fungus and responsible for a broad spectrum of lung disease depending on the patient's immune status and underlying lung disease. Due to a preexisting lung cavity from a variety of causes, such as pulmonary tuberculosis, excavated lung cancer, sarcoidosis, or pneumoconiosis, aspergillus can colonize and grow into the cavity to form a pulmonary aspergilloma (fungus ball).
METHODS: We conducted a retrospective study in order to evaluate the frequency of intracavitary aspergilloma on underlying lung disease and also to evaluate the efficiency of surgical interventions. 69 patients admitted in "Leon-Daniello" Pneumology Clinical Hospital in the last 20 years, with suspicion of aspergilloma were evaluated.
RESULTS: From those 49 (71.01%) were males and 20 (28.98%) were females, mean age was 57.38±10.52. In 5/69 (7.24%) cases the primary diagnosis was pulmonary adenocarcinoma, 4/69 (5.79%) was sarcoidosis, 1/69 (1.44%) was pneumoconiosis and in the rest of the cases 59/69 (85.50%), intracavitary aspergilloma was present on sequelare lesions and also with active bacillary lesion. A significant statistical correlation was found for the development of aspergilloma on a preexisting pulmonary tuberculosis (p<0.00001), especially for sequelare lesions (p<0.0001). Surgical therapy was applied in 40 cases (57.97%) using lobe exeresis, atypical resection and cavernoplasty. One year post surgical treatment, 32 (77.5%) cases had a favorable evolution and the other cases were lost of follow-up.
CONCLUSIONS: The pulmonary aspergilloma develops most commonly on an underlying disease such as pulmonary tuberculosis, especially sequelare tuberculosis cavities.
CLINICAL IMPLICATIONS: As clinicians, we need to direct our attention to a most carefull monitoring of patients with pulmonary sequelare tuberulosis, even screening methods, due to the high risk of developing pulmonary aspergillosis.
DISCLOSURE: The following authors have nothing to disclose: Doina Adina Todea, Paraschiva Postolache, Loredana Elena Rosca, Andreea Codruta ComanNo Product/Research Disclosure Information.
METHODS: We conducted a retrospective study in order to evaluate the frequency of intracavitary aspergilloma on underlying lung disease and also to evaluate the efficiency of surgical interventions. 69 patients admitted in "Leon-Daniello" Pneumology Clinical Hospital in the last 20 years, with suspicion of aspergilloma were evaluated.
RESULTS: From those 49 (71.01%) were males and 20 (28.98%) were females, mean age was 57.38±10.52. In 5/69 (7.24%) cases the primary diagnosis was pulmonary adenocarcinoma, 4/69 (5.79%) was sarcoidosis, 1/69 (1.44%) was pneumoconiosis and in the rest of the cases 59/69 (85.50%), intracavitary aspergilloma was present on sequelare lesions and also with active bacillary lesion. A significant statistical correlation was found for the development of aspergilloma on a preexisting pulmonary tuberculosis (p<0.00001), especially for sequelare lesions (p<0.0001). Surgical therapy was applied in 40 cases (57.97%) using lobe exeresis, atypical resection and cavernoplasty. One year post surgical treatment, 32 (77.5%) cases had a favorable evolution and the other cases were lost of follow-up.
CONCLUSIONS: The pulmonary aspergilloma develops most commonly on an underlying disease such as pulmonary tuberculosis, especially sequelare tuberculosis cavities.
CLINICAL IMPLICATIONS: As clinicians, we need to direct our attention to a most carefull monitoring of patients with pulmonary sequelare tuberulosis, even screening methods, due to the high risk of developing pulmonary aspergillosis.
DISCLOSURE: The following authors have nothing to disclose: Doina Adina Todea, Paraschiva Postolache, Loredana Elena Rosca, Andreea Codruta ComanNo Product/Research Disclosure Information.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Diagnosis and Management of Cardiac Sarcoidosis: A Scientific Statement From the American Heart Association.Circulation 2024 April 19
Essential thrombocythaemia: A contemporary approach with new drugs on the horizon.British Journal of Haematology 2024 April 9
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app